SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guidant (GDT)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lance Bredvold who wrote (230)2/13/2006 12:07:16 PM
From: X-Ray Man  Read Replies (1) of 235
 
Yes, I understand that. But what is odd is that GDT is trading just at $75 for some days, but BSX is trading at $22, or near the price the deal was made at. Hence, this deal should still be worth today $80/share. So, I suspect something else is at work here. Either the expectation is that the deal will not necessarily go through (either BSX will back out, or Abbot, or there will be regulatory issues), or the price may simply be pinned right now upon expiration of options at the end of the week.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News